CRN RECOMMENDS CONGRESSIONAL OVERSIGHT OF FDA's FOLIC ACID HEALTH CLAIM
This article was originally published in The Tan Sheet
CRN RECOMMENDS CONGRESSIONAL OVERSIGHT OF FDA's FOLIC ACID HEALTH CLAIM and the agency "s process in developing the claim. Speaking at a Feb. 18 "town meeting" convened by Rep. Elton Gallegly (R-Calif.) in Ventura, Calif., Council for Responsible Nutrition President J.B. Cordaro suggested that Congress "examine the clumsy, plodding and time-consuming process whereby FDA finally arrived at a folic acid claim which was focused on conventional food."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC